Catalyst Wire Dossier Catalyst Wire Dossier

Survivin peptide vaccine

Survivin peptide vaccine · Julius-Maximilians University Würzburg
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Survivin peptide vaccine, covering 2006-07-28 to 2006-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer [Phase 1, Phase 2]

See pricing